Cardiovascular and renal effects of carperitide and nesiritide in cardiovascular surgery patients: a systematic review and meta-analysis
Open Access
- 27 October 2011
- journal article
- research article
- Published by Springer Nature in Critical Care
- Vol. 15 (5) , R258
Abstract
Introduction: Acute kidney injury (AKI) following cardiovascular surgery is a common disease process and is associated with both morbidity and mortality. The aim of our study was to evaluate the cardiovascular and renal effects of an atrial natriuretic peptide (ANP, carperitide) and a B-type (or brain) natriuretic peptide (BNP, nesiritide) for preventing and treating AKI in cardiovascular surgery patients. Methods: Electronic databases, including PubMed, EMBASE and references from identified articles were used for a literature search. Results: Data on the infusion of ANP or BNP in cardiovascular surgery patients was collected from fifteen randomized controlled trials and combined. The infusion of ANP or BNP increased the urine output and creatinine clearance or glomerular filtration rate, and reduced the use of diuretics and the serum creatinine levels. A meta-analysis showed that ANP infusion significantly decreased peak serum creatinine levels, incidence of arrhythmia and renal replacement therapy. The meta-analysis also showed that ANP or BNP infusion significantly decreased the length of ICU stay and hospital stay compared with controls. However, the combined data were insufficient to determine how ANP or BNP infusion during the perioperative period influences long-term outcome in cardiovascular surgery patients. Conclusions: The infusion of ANP or BNP may preserve postoperative renal function in cardiovascular surgery patients. A large, multicenter, prospective, randomized controlled trial will have to be performed to assess the therapeutic potential of ANP or BNP in preventing and treating AKI in the cardiovascular surgical setting.Keywords
This publication has 48 references indexed in Scilit:
- Suprarenal aortic cross-clamp position: A reappraisal of its effects on outcomes for open abdominal aortic aneurysm repairJournal of Vascular Surgery, 2009
- Effects of human atrial natriuretic peptide on renal function in patients undergoing abdominal aortic aneurysm repair*Critical Care Medicine, 2008
- SCN4B -Encoded Sodium Channel β4 Subunit in Congenital Long-QT SyndromeCirculation, 2007
- Meta-analysis of frusemide to prevent or treat acute renal failureBMJ, 2006
- Effects of human atrial natriuretic peptide on cardiac function and hemodynamics in patients with high plasma BNP levelsInternational Journal of Cardiology, 2005
- Vascular and renal actions of brain natriuretic peptide in man: physiology and pharmacologyFundamental & Clinical Pharmacology, 2005
- Long-Term Outcome of Isolated Coronary Artery Bypass Surgery in Patients With Severe Left Ventricular DysfunctionCirculation, 2004
- Autocrine and paracrine actions of natriuretic peptides in the heartPharmacology & Therapeutics, 2004
- Atrial natriuretic peptide infusion improves ischemic renal failure after suprarenal abdominal aortic cross-clamping in dogsCritical Care Medicine, 2003
- Atrial natriuretic peptide protects against acute ischemic renal failure in the rat.Journal of Clinical Investigation, 1987